Comparison of the preparation of PLGA-BSA nano- and microparticles by PVA, poloxamer and PVP

被引:80
作者
Feczko, Tivadar [1 ,2 ]
Toth, Judit [1 ,2 ]
Gyenis, Janos [2 ]
机构
[1] HAS, Chem Res Ctr, Inst Mat & Environm Chem, H-1025 Budapest, Hungary
[2] Univ Pannonia, Res Inst Chem & Proc Engn, H-8200 Veszprem, Hungary
关键词
nano- and microparticles; polyvinyl alcohol; poloxamer; polyvinyl pyrrolidone;
D O I
10.1016/j.colsurfa.2007.07.011
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The objective of our study was to prepare nano- and microparticles economically considering some practical parameters such as size and encapsulation efficiency as well as ability of particle recovery. Bovine serum albumin (BSA) model protein was encapsulated by poly(D,L-lactideco-glycolide) (PLGA) using a multiple water-in-oil-in-water emulsion-solvent evaporation technique. The effect of three surfactants: polyvinyl alcohol, poloxamer, and polyvinyl pyrrolidone, used in the outer water phase, on the properties of particles was investigated. The emulsifier/PLGA mass ratio played an important role in the preparation procedure of the particles. This ratio was found to be approximately I for polyvinyl alcohol (PVA) if the aim was to formulate nanoparticles with narrow size distribution (<220 nm), high yield and good encapsulation efficiency (>90%). Although, a ratio of 2:1 was sufficient to produce submicron particles by poloxamer with high yield, more than 70% and 90% encapsulation efficiency required minimum 4 and 10 emulsifier/PLGA mass ratio, respectively. Five times more PVA and 10 times more poloxamer than the PLGA mass were necessary to obtain nanoparticles which were easy to redisperse after centrifugation. Microparticles released more BSA than nanoparticles prepared by PVA, however, the situation was reverse with poloxamer. Microparticles formulated by polyvinyl pyrrolidone (PVP) showed the fastest in vitro release. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 195
页数:8
相关论文
共 21 条
[1]   Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[2]   The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method [J].
Coombes, AGA ;
Yeh, MK ;
Lavelle, EC ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (03) :311-320
[3]   The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent [J].
Desai, MP ;
Labhasetwar, V ;
Walter, E ;
Levy, RJ ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1997, 14 (11) :1568-1573
[4]  
EROS I, 1990, PHARMAZIE, V45, P419
[5]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490
[6]   THE UPTAKE AND TRANSLOCATION OF LATEX NANOSPHERES AND MICROSPHERES AFTER ORAL-ADMINISTRATION TO RATS [J].
JANI, P ;
HALBERT, GW ;
LANGRIDGE, J ;
FLORENCE, AT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (12) :809-+
[7]   How porosity and size affect the drug release mechanisms from PLIGA-based microparticles [J].
Klose, D. ;
Siepmann, F. ;
Elkharraz, K. ;
Krenzlin, S. ;
Siepmann, J. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 314 (02) :198-206
[8]   Structural analysis of w/o/w multiple emulsions by means of DSC [J].
Kovács, A ;
Csóka, I ;
Kónya, M ;
Csányi, E ;
Fehér, A ;
Eros, I .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2005, 82 (02) :491-497
[9]   Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification [J].
Lamprecht, A ;
Ubrich, N ;
Pérez, MH ;
Lehr, CM ;
Hoffman, M ;
Maincent, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :97-105
[10]   Polymeric nanoparticles as delivery system for influenza virus glycoproteins [J].
Lemoine, D ;
Preat, V .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (01) :15-27